Zinman B, et al. Cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373:2117–28. Empagliflozin.Article CAS PubMed ...
Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and...
Share on PinterestNew research indicates that people with CKM syndrome may have a higher risk of developing cardiovascular disease up...
The Endocrine Society, a global organization that promotes endocrinology research and clinical practice, and Keystone Symposia, a nonprofit host of...
Consequences of stability of metabolic health versus transition to a metabolically unhealthy phenotype for cardiovascular disease risk. Credit: Nature Reviews...
